Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Back To The Future? Old Drugs, New Purposes

This article was originally published in Scrip

Executive Summary

Going back to the future has been a bit of a theme for pharma recently, and not because Oct. 21 2015, was the date that Marty McFly and Doc Brown traveled to in Back to the Future II. Recent developments picked up by the media at large include a new use for insulin (in diabetes), and a "miracle" new cure for Parkinson's disease (Novartis' leukemia drug Tasigna (nilotinib), which was first approved in 2007).

Advertisement

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC030107

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel